Structure of HIV-1 RRE stem-loop II identifies two conformational states of the high-affinity Rev binding site.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 May 2024
Historique:
received: 17 11 2023
accepted: 22 04 2024
medline: 18 5 2024
pubmed: 18 5 2024
entrez: 17 5 2024
Statut: epublish

Résumé

During HIV infection, specific RNA-protein interaction between the Rev response element (RRE) and viral Rev protein is required for nuclear export of intron-containing viral mRNA transcripts. Rev initially binds the high-affinity site in stem-loop II, which promotes oligomerization of additional Rev proteins on RRE. Here, we present the crystal structure of RRE stem-loop II in distinct closed and open conformations. The high-affinity Rev-binding site is located within the three-way junction rather than the predicted stem IIB. The closed and open conformers differ in their non-canonical interactions within the three-way junction, and only the open conformation has the widened major groove conducive to initial Rev interaction. Rev binding assays show that RRE stem-loop II has high- and low-affinity binding sites, each of which binds a Rev dimer. We propose a binding model, wherein Rev-binding sites on RRE are sequentially created through structural rearrangements induced by Rev-RRE interactions.

Identifiants

pubmed: 38760344
doi: 10.1038/s41467-024-48162-y
pii: 10.1038/s41467-024-48162-y
doi:

Substances chimiques

rev protein, Human Immunodeficiency Virus-1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4198

Subventions

Organisme : University of Texas Medical Branch (University of Texas Medical Branch at Galveston)
ID : Kempner pre-doctoral fellowship

Informations de copyright

© 2024. The Author(s).

Références

Mölling, K. et al. Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nat. N. Biol. 234, 240–243 (1971).
doi: 10.1038/newbio234240a0
Esposito, D. & Craigie, R. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J. 17, 5832–5843 (1998).
pubmed: 9755183 pmcid: 1170911 doi: 10.1093/emboj/17.19.5832
Frankel, A. D. & Young, J. A. HIV-1: fifteen proteins and an RNA. Annu. Rev. Biochem. 67, 1–25 (1998).
pubmed: 9759480 doi: 10.1146/annurev.biochem.67.1.1
Purcell, D. F. & Martin, M. A. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 67, 6365–6378 (1993).
pubmed: 8411338 pmcid: 238071 doi: 10.1128/jvi.67.11.6365-6378.1993
Rosen, C. A. Tat and Rev: positive modulators of human immunodeficiency virus gene expression. Gene Expr. 1, 85–90 (1991).
pubmed: 1820213
Anand, K., Schulte, A., Vogel-Bachmayr, K., Scheffzek, K. & Geyer, M. Structural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAV. Nat. Struct. Mol. Biol. 15, 1287–1292 (2008).
pubmed: 19029897 doi: 10.1038/nsmb.1513
Rausch, J. W. & Le Grice, S. F. HIV Rev assembly on the Rev response element (RRE): a structural perspective. Viruses 7, 3053–3075 (2015).
pubmed: 26075509 pmcid: 4488727 doi: 10.3390/v7062760
Karn, J. & Stoltzfus, C. M. Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harb. Perspect. Med. 2, a006916 (2012).
pubmed: 22355797 pmcid: 3281586 doi: 10.1101/cshperspect.a006916
Laspia, M. F., Rice, A. P. & Mathews, M. B. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59, 283–292 (1989).
pubmed: 2553266 doi: 10.1016/0092-8674(89)90290-0
Marciniak, R. A., Calnan, B. J., Frankel, A. D. & Sharp, P. A. HIV-1 Tat protein trans-activates transcription in vitro. Cell 63, 791–802 (1990).
pubmed: 2225077 doi: 10.1016/0092-8674(90)90145-5
Feinberg, M. B., Baltimore, D. & Frankel, A. D. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl Acad. Sci. USA 88, 4045–4049 (1991).
pubmed: 2023953 pmcid: 51590 doi: 10.1073/pnas.88.9.4045
Hammarskjöld, M. L. et al. Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63, 1959–1966 (1989).
pubmed: 2704072 pmcid: 250609 doi: 10.1128/jvi.63.5.1959-1966.1989
Pollard, V. W. & Malim, M. H. The HIV-1 Rev protein. Annu. Rev. Microbiol 52, 491–532 (1998).
pubmed: 9891806 doi: 10.1146/annurev.micro.52.1.491
Böhnlein, E., Berger, J. & Hauber, J. Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex. J. Virol. 65, 7051–7055 (1991).
pubmed: 1942257 pmcid: 250826 doi: 10.1128/jvi.65.12.7051-7055.1991
Malim, M. H., Hauber, J., Le, S. Y., Maizel, J. V. & Cullen, B. R. The HIV-1 Rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254–257 (1989).
pubmed: 2784194 doi: 10.1038/338254a0
Watts, J. M. et al. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460, 711–716 (2009).
pubmed: 19661910 pmcid: 2724670 doi: 10.1038/nature08237
Bai, Y., Tambe, A., Zhou, K. & Doudna, J. A. RNA-guided assembly of Rev-RRE nuclear export complexes. Elife 3, e03656 (2014).
pubmed: 25163983 pmcid: 4142337 doi: 10.7554/eLife.03656
Fang, X. et al. An unusual topological structure of the HIV-1 Rev response element. Cell 155, 594–605 (2013).
pubmed: 24243017 pmcid: 3918456 doi: 10.1016/j.cell.2013.10.008
Legiewicz, M. et al. Resistance to RevM10 inhibition reflects a conformational switch in the HIV-1 Rev response element. Proc. Natl Acad. Sci. USA 105, 14365–14370 (2008).
pubmed: 18776047 pmcid: 2567145 doi: 10.1073/pnas.0804461105
Cook, K. S. et al. Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res. 19, 1577–1583 (1991).
pubmed: 2027765 pmcid: 333918 doi: 10.1093/nar/19.7.1577
Heaphy, S., Finch, J. T., Gait, M. J., Karn, J. & Singh, M. Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich “bubble” located within the rev-responsive region of viral mRNAs. Proc. Natl Acad. Sci. USA 88, 7366–7370 (1991).
pubmed: 1871141 pmcid: 52296 doi: 10.1073/pnas.88.16.7366
Daugherty, M. D., D’Orso, I. & Frankel, A. D. A solution to limited genomic capacity: using adaptable binding surfaces to assemble the functional HIV Rev oligomer on RNA. Mol. Cell 31, 824–834 (2008).
pubmed: 18922466 pmcid: 2651398 doi: 10.1016/j.molcel.2008.07.016
Mann, D. A. et al. A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression. J. Mol. Biol. 241, 193–207 (1994).
pubmed: 8057359 doi: 10.1006/jmbi.1994.1488
O’Carroll, I. P. et al. Contributions of individual domains to function of the HIV-1 Rev response element. J. Virol. 91, e00746–17 (2017).
pubmed: 28814520 pmcid: 5640835
Daly, T. J., Cook, K. S., Gray, G. S., Maione, T. E. & Rusche, J. R. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature 342, 816–819 (1989).
pubmed: 2481237 doi: 10.1038/342816a0
Tiley, L. S., Malim, M. H., Tewary, H. K., Stockley, P. G. & Cullen, B. R. Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc. Natl Acad. Sci. USA 89, 758–762 (1992).
pubmed: 1731351 pmcid: 48318 doi: 10.1073/pnas.89.2.758
Daly, T. J. et al. Biochemical characterization of binding of multiple HIV-1 Rev monomeric proteins to the Rev responsive element. Biochemistry 32, 10497–10505 (1993).
pubmed: 8399195 doi: 10.1021/bi00090a028
Malim, M. H., Böhnlein, S., Hauber, J. & Cullen, B. R. Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell 58, 205–214 (1989).
pubmed: 2752419 doi: 10.1016/0092-8674(89)90416-9
Malim, M. H. & Cullen, B. R. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 65, 241–248 (1991).
pubmed: 2015625 doi: 10.1016/0092-8674(91)90158-U
Daelemans, D., Costes, S. V., Lockett, S. & Pavlakis, G. N. Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo. Mol. Cell Biol. 25, 728–739 (2005).
pubmed: 15632073 pmcid: 543413 doi: 10.1128/MCB.25.2.728-739.2005
Fornerod, M., Ohno, M., Yoshida, M. & Mattaj, I. W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90, 1051–1060 (1997).
pubmed: 9323133 doi: 10.1016/S0092-8674(00)80371-2
Neville, M., Stutz, F., Lee, L., Davis, L. I. & Rosbash, M. The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr. Biol. 7, 767–775 (1997).
pubmed: 9368759 doi: 10.1016/S0960-9822(06)00335-6
Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W. & Lührmann, R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82, 475–483 (1995).
pubmed: 7543368 doi: 10.1016/0092-8674(95)90436-0
Booth, D. S., Cheng, Y. & Frankel, A. D. The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA. Elife 3, e04121 (2014).
pubmed: 25486595 pmcid: 4360530 doi: 10.7554/eLife.04121
Askjaer, P., Jensen, T. H., Nilsson, J., Englmeier, L. & Kjems, J. The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP. J. Biol. Chem. 273, 33414–33422 (1998).
pubmed: 9837918 doi: 10.1074/jbc.273.50.33414
Zemmel, R. W., Kelley, A. C., Karn, J. & Butler, P. J. Flexible regions of RNA structure facilitate co-operative Rev assembly on the Rev-response element. J. Mol. Biol. 258, 763–777 (1996).
pubmed: 8637008 doi: 10.1006/jmbi.1996.0285
Tanamura, S., Terakado, H. & Harada, K. Cooperative dimerization of a stably folded protein directed by a flexible RNA in the assembly of the HIV Rev dimer-RRE stem II complex. J. Mol. Recognit. 29, 199–209 (2016).
pubmed: 26620599 doi: 10.1002/jmr.2518
Schneeberger, E. M. et al. Native mass spectrometry reveals the initial binding events of HIV-1 rev to RRE stem II RNA. Nat. Commun. 11, 5750 (2020).
pubmed: 33188169 pmcid: 7666190 doi: 10.1038/s41467-020-19144-7
Lee, E. et al. Structures of flavivirus RNA promoters suggest two binding modes with NS5 polymerase. Nat. Commun. 12, 2530 (2021).
pubmed: 33953197 pmcid: 8100141 doi: 10.1038/s41467-021-22846-1
Gottipati, K., McNeme, S. C., Tipo, J., White, M. A. & Choi, K. H. Structural basis for cloverleaf RNA-initiated viral genome replication. Nucleic Acids Res. 51, 8850–8863 (2023).
pubmed: 37486760 pmcid: 10484678 doi: 10.1093/nar/gkad618
Bartel, D. P., Zapp, M. L., Green, M. R. & Szostak, J. W. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67, 529–536 (1991).
pubmed: 1934059 doi: 10.1016/0092-8674(91)90527-6
Lescoute, A. & Westhof, E. Topology of three-way junctions in folded RNAs. RNA 12, 83–93 (2006).
pubmed: 16373494 pmcid: 1370888 doi: 10.1261/rna.2208106
Holland, S. M., Chavez, M., Gerstberger, S. & Venkatesan, S. A specific sequence with a bulged guanosine residue(s) in a stem-bulge-stem structure of Rev-responsive element RNA is required for trans activation by human immunodeficiency virus type 1 Rev. J. Virol. 66, 3699–3706 (1992).
pubmed: 1583728 pmcid: 241154 doi: 10.1128/jvi.66.6.3699-3706.1992
Rypniewski, W., Adamiak, D. A., Milecki, J. & Adamiak, R. W. Noncanonical G(syn)-G(anti) base pairs stabilized by sulphate anions in two X-ray structures of the (GUGGUCUGAUGAGGCC) RNA duplex. RNA 14, 1845–1851 (2008).
pubmed: 18658118 pmcid: 2525959 doi: 10.1261/rna.1164308
Sokoloski, J. E., Godfrey, S. A., Dombrowski, S. E. & Bevilacqua, P. C. Prevalence of syn nucleobases in the active sites of functional RNAs. RNA 17, 1775–1787 (2011).
pubmed: 21873463 pmcid: 3185911 doi: 10.1261/rna.2759911
Jayaraman, B. et al. RNA-directed remodeling of the HIV-1 protein Rev orchestrates assembly of the Rev-Rev response element complex. Elife 3, e04120 (2014).
pubmed: 25486594 pmcid: 4360532 doi: 10.7554/eLife.04120
Tan, R., Chen, L., Buettner, J. A., Hudson, D. & Frankel, A. D. RNA recognition by an isolated alpha helix. Cell 73, 1031–1040 (1993).
pubmed: 7684657 doi: 10.1016/0092-8674(93)90280-4
Zhang, G., Zapp, M. L., Yan, G. & Green, M. R. Localization of HIV-1 RNA in mammalian nuclei. J. Cell Biol. 135, 9–18 (1996).
pubmed: 8858159 doi: 10.1083/jcb.135.1.9
Perkins, A., Cochrane, A. W., Ruben, S. M. & Rosen, C. A. Structural and functional characterization of the human immunodeficiency virus rev protein. J. Acquir. Immune Defic. Syndr. 2, 256–263 (1989).
pubmed: 2656990
Zapp, M. L. & Green, M. R. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342, 714–716 (1989).
pubmed: 2556643 doi: 10.1038/342714a0
Bogerd, H. & Greene, W. C. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J. Virol. 67, 2496–2502 (1993).
pubmed: 8474155 pmcid: 237568 doi: 10.1128/jvi.67.5.2496-2502.1993
Madore, S. J., Tiley, L. S., Malim, M. H. & Cullen, B. R. Sequence requirements for Rev multimerization in vivo. Virology 202, 186–194 (1994).
pubmed: 7516596 doi: 10.1006/viro.1994.1334
Ippolito, J. A. & Steitz, T. A. The structure of the HIV-1 RRE high affinity rev binding site at 1.6 A resolution. J. Mol. Biol. 295, 711–717 (2000).
pubmed: 10656783 doi: 10.1006/jmbi.1999.3405
Hung, L. W., Holbrook, E. L. & Holbrook, S. R. The crystal structure of the Rev binding element of HIV-1 reveals novel base pairing and conformational variability. Proc. Natl Acad. Sci. USA 97, 5107–5112 (2000).
pubmed: 10792052 pmcid: 25789 doi: 10.1073/pnas.090588197
Battiste, J. L. et al. Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex. Science 273, 1547–1551 (1996).
pubmed: 8703216 doi: 10.1126/science.273.5281.1547
Ye, X., Gorin, A., Ellington, A. D. & Patel, D. J. Deep penetration of an alpha-helix into a widened RNA major groove in the HIV-1 rev peptide-RNA aptamer complex. Nat. Struct. Biol. 3, 1026–1033 (1996).
pubmed: 8946856 doi: 10.1038/nsb1296-1026
Jain, C. & Belasco, J. G. Structural model for the cooperative assembly of HIV-1 Rev multimers on the RRE as deduced from analysis of assembly-defective mutants. Mol. Cell 7, 603–614 (2001).
pubmed: 11463385 doi: 10.1016/S1097-2765(01)00207-6
Zapp, M. L., Hope, T. J., Parslow, T. G. & Green, M. R. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc. Natl Acad. Sci. USA 88, 7734–7738 (1991).
pubmed: 1715576 pmcid: 52377 doi: 10.1073/pnas.88.17.7734
Kjems, J. & Sharp, P. A. The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. J. Virol. 67, 4769–4776 (1993).
pubmed: 8331728 pmcid: 237863 doi: 10.1128/jvi.67.8.4769-4776.1993
Daugherty, M. D., Liu, B. & Frankel, A. D. Structural basis for cooperative RNA binding and export complex assembly by HIV Rev. Nat. Struct. Mol. Biol. 17, 1337–1342 (2010).
pubmed: 20953181 pmcid: 2988976 doi: 10.1038/nsmb.1902
Watts, N. R. et al. A new HIV-1 Rev structure optimizes interaction with target RNA (RRE) for nuclear export. J. Struct. Biol. 203, 102–108 (2018).
pubmed: 29605570 pmcid: 6019186 doi: 10.1016/j.jsb.2018.03.011
Hammond, J. A., Lamichhane, R., Millar, D. P. & Williamson, J. R. A DEAD-Box helicase mediates an RNA structural transition in the HIV-1 Rev response element. J. Mol. Biol. 429, 697–714 (2017).
pubmed: 28153748 pmcid: 5510989 doi: 10.1016/j.jmb.2017.01.018
Lamichhane, R. et al. A DEAD-box protein acts through RNA to promote HIV-1 Rev-RRE assembly. Nucleic Acids Res. 45, 4632–4641 (2017).
pubmed: 28379444 pmcid: 5416872 doi: 10.1093/nar/gkx206
Jackson, P. E., Tebit, D. M., Rekosh, D. & Hammarskjold, M. L. Rev-RRE functional activity differs substantially among primary HIV-1 isolates. AIDS Res. Hum. Retroviruses 32, 923–934 (2016).
pubmed: 27147495 pmcid: 5028908 doi: 10.1089/aid.2016.0047
Sloan, E. A. et al. Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization. J. Virol. 87, 11173–11186 (2013).
pubmed: 23926352 pmcid: 3807272 doi: 10.1128/JVI.01392-13
Ponchon, L. & Dardel, F. Recombinant RNA technology: the tRNA scaffold. Nat. Methods 4, 571–576 (2007).
pubmed: 17558412 doi: 10.1038/nmeth1058
Kerpedjiev, P., Hammer, S. & Hofacker, I. L. Forna (force-directed RNA): simple and effective online RNA secondary structure diagrams. Bioinformatics 31, 3377–3379 (2015).
pubmed: 26099263 pmcid: 4595900 doi: 10.1093/bioinformatics/btv372
Milligan, J. F., Groebe, D. R., Witherell, G. W. & Uhlenbeck, O. C. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 15, 8783–8798 (1987).
pubmed: 3684574 pmcid: 306405 doi: 10.1093/nar/15.21.8783
Guillerez, J., Lopez, P. J., Proux, F., Launay, H. & Dreyfus, M. A mutation in T7 RNA polymerase that facilitates promoter clearance. Proc. Natl Acad. Sci. USA 102, 5958–5963 (2005).
pubmed: 15831591 pmcid: 1087904 doi: 10.1073/pnas.0407141102
Daugherty, M. D., Booth, D. S., Jayaraman, B., Cheng, Y. & Frankel, A. D. HIV Rev response element (RRE) directs assembly of the Rev homooligomer into discrete asymmetric complexes. Proc. Natl Acad. Sci. USA 107, 12481–12486 (2010).
pubmed: 20616058 pmcid: 2906596 doi: 10.1073/pnas.1007022107
Newman, J. et al. Towards rationalization of crystallization screening for small- to medium-sized academic laboratories: the PACT/JCSG+ strategy. Acta Crystallogr. D Biol. Crystallogr. 61, 1426–1431 (2005).
pubmed: 16204897 doi: 10.1107/S0907444905024984
Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 (2010).
pubmed: 20124692 pmcid: 2815665 doi: 10.1107/S0907444909047337
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861–877 (2019).
pubmed: 31588918 pmcid: 6778852 doi: 10.1107/S2059798319011471
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
pubmed: 15264254 doi: 10.1002/jcc.20084

Auteurs

Jerricho Tipo (J)

Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, 77555, USA.
Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, 47405, USA.

Keerthi Gottipati (K)

Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, 47405, USA.

Michael Slaton (M)

Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, 47405, USA.

Giovanni Gonzalez-Gutierrez (G)

Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, 47405, USA.

Kyung H Choi (KH)

Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX, 77555, USA. kaychoi@iu.edu.
Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, 47405, USA. kaychoi@iu.edu.
Department of Biochemistry and Molecular Biology, Sealy Center for Structural Biology, The University of Texas Medical Branch, Galveston, TX, 77555, USA. kaychoi@iu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH